Your browser doesn't support javascript.
loading
Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle.
Vaz, Karl; Kemp, William; Majeed, Ammar; Lubel, John; Magliano, Dianna J; Glenister, Kristen M; Bourke, Lisa; Simmons, David; Roberts, Stuart K.
Afiliación
  • Vaz K; Department of Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.
  • Kemp W; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Majeed A; Department of Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.
  • Lubel J; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Magliano DJ; Department of Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.
  • Glenister KM; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Bourke L; Department of Gastroenterology and Hepatology, Alfred Health, Melbourne, Victoria, Australia.
  • Simmons D; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Roberts SK; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
J Gastroenterol Hepatol ; 38(10): 1823-1831, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37571988
ABSTRACT
BACKGROUND AND

AIM:

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver condition globally. The aim of this study was to evaluate the change in age- and sex-standardized prevalence of NAFLD in regional Victoria over a 15-year period and explore the underlying factors associated with differences over time.

METHODS:

Repeated comparative cross-sectional studies in four towns in regional Victoria, Australia. Individuals randomly selected from households from residential address lists from local government organizations in 2001-2003 (CrossRoads I [CR1]) and 2016-2018 (CrossRoads II [CR2]) with 1040 (99%) and 704 (94%) participants from CR1 and CR2 having complete data for analysis. Primary outcome was change in prevalence estimates of NAFLD (defined by a fatty liver index ≥ 60 in the absence of excess alcohol and viral hepatitis) between 2003 and 2018.

RESULTS:

Crude prevalence of NAFLD increased from 32.7% to 38.8% (P < 0.01), while age-standardized/sex-standardized prevalence increased from 32.4% to 35.4% (P < 0.01). Concurrently, prevalence of obesity defined by BMI and elevated waist circumference increased 28% and 25%, respectively. Women had a greater increase in the prevalence of NAFLD than men, in parallel with increasing prevalence of obesity. Proportion of participants consuming takeaway food greater than once weekly increased significantly over time. Up to 60% of NAFLD patients require additional tests for assessment of significant fibrosis.

CONCLUSIONS:

Crude and age-standardized/sex-standardized prevalence of NAFLD have both increased significantly over the last 15 years, particularly among women, in association with a parallel rise in the prevalence of obesity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Female / Humans / Male Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Australia